Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by ISAloser247on Nov 19, 2010 2:22pm
744 Views
Post# 17731263

PSORIASIS UPDATE, ANYONE?.....

PSORIASIS UPDATE, ANYONE?.....
........lost in the FDA submission failure postings of August, 2010 was this blurb in FierceBiotech, Aug/09/2010


"The Pharmacor 2010 findings also reveal that none of the oral agents in development which include Isotechnika Pharma's voclosporin and Celgene's apremilat appear to offer major advantages over marketed systemic therapies, and their potential launch is not expected to have a notable impact on the psoriasis drug market over the next decade."



......IS THAT ZANY OR WHAT?

<< Previous
Bullboard Posts
Next >>